Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence

Published:2017-01-29 Issue:4 Volume:10 Page:391-400
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

McConachie Sean¹,Wilhelm Sheila M.²³^ORCID,Kale-Pradhan Pramodini B.²⁴^ORCID

Affiliation:

1. Department of Pharmacy, Harper University Hospital , Detroit, MI, USA

2. Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University , Detroit, MI, USA

3. Harper University Hospital , Detroit, MI, USA

4. St. John Hospital and Medical Center , Detroit, MI, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1283983

Reference86 articles.

1. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases

2. Biosimilars: A Multidisciplinary Perspective

3. Development of biosimilars

4. Current status of biosimilars in the treatment of inflammatory bowel diseases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA;Expert Opinion on Biological Therapy;2020-11-01

2. Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN;Journal of Pediatric Gastroenterology & Nutrition;2019-01

3. Actualización sobre los medicamentos biocomparables en la enfermedad inflamatoria intestinal: posición y recomendación en México;Revista de Gastroenterología de México;2018-10

4. Update on biosimilars in inflammatory bowel disease: Position and recommendations in Mexico;Revista de Gastroenterología de México (English Edition);2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3